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 ABSTRACT 
 The use of oral rehydration solutions (ORS) is well 
established as an effective treatment to correct water-, 
electrolyte-, and acid-base balance in diarrheic calves. 
The main ingredients of a commercial ORS are Na, 
glucose, and alkalinizing agents, such as NaHCO3. 
Particular importance is attributed to the combina-
tion of glucose and Na at a specific ratio to optimize 
intestinal sodium, and thereby water uptake, through 
the sodium-glucose co-transport. Enhancing intestinal 
Na absorption by combining glucose and Na in an ORS 
has the potential to improve the alkalinizing effect of 
an ORS according the strong ion theory. The objective 
of this study was to investigate the effect of glucose on 
the alkalinizing effect of NaHCO3 when administered 
orally. Nine healthy neonatal Holstein-Friesian calves 
underwent 3 oral treatments with 2-L solutions of NaH-
CO3 (150 mmol/L), glucose (300 mmol/L), and glucose 
+ NaHCO3 (300 mmol/L + 150 mmol/L, respectively) 
in randomized order. Arterial and venous blood was 
obtained before treatment and in 30-min intervals 
thereafter for blood gas analysis and determination of 
plasma protein and electrolyte concentrations. Urine 
was collected volumetrically to determine urine volume, 
osmolality, pH, net acid excretion, and renal Na excre-
tion after treatment. Plasma volume changes were ex-
trapolated from plasma protein concentration changes. 
Treatment and time effects were tested with repeated 
measures ANOVA. Only subtle differences between oral 
administration of NaHCO3, with and without glucose, 
were observed for the change of the standard HCO3
concentration relative to baseline. No differences in 
plasma Na, plasma volume expansion, renal Na, net 
base excretion, urine volume, or pH could be identi-
fied between animals treated orally with NaHCO3 with 
and without glucose. Similarly, no differences in blood 
glucose concentration, plasma volume expansion, urine 
volume, or renal glucose excretion were observed in the 
8 h after treatment when comparing oral glucose treat-
ment with and without NaHCO3. Our results indicate 
that combination of NaHCO3 with glucose in a hyper-
tonic ORS only had a minor effect on the alkalinizing 
effect of NaHCO3, which is unlikely to be of clinical 
relevance. The combination of NaHCO3 and glucose 
neither improved Na, glucose, nor water absorption 
in euhydrated neonatal dairy calves, questioning the 
relevance of a specific ratio between Na and glucose in 
ORS for calves. 
 Key words:   oral electrolyte solution ,  calf ,  glucose , 
 sodium bicarbonate 
 INTRODUCTION 
 Diarrhea is the main cause for morbidity in dairy 
calves, accounting for more than 50% of losses in 
unweaned dairy calves in the United States (USDA, 
2007). Economic losses associated with diarrhea in 
calves are not only due to increased mortality rates, 
but also to labor, medication, and veterinary expenses. 
Besides resulting in dehydration, diarrhea is frequently 
associated with acidemia, metabolic acidosis, electro-
lyte imbalances, and hypoglycemia (Naylor, 1999). For 
mildly to moderately affected calves, oral rehydration 
therapy provides an easily applicable, efficient, and in-
expensive treatment approach in farm animal practice. 
Oral rehydration solutions (ORS), when formulated 
correctly, can efficiently correct moderate dehydration, 
acidemia, hyperkalemia, and hypoglycemia. Effective 
ORS are required to provide (1) adequate amounts of 
Na to correct and maintain extracellular volume ho-
meostasis; (2) sufficient organic compounds, such as 
glucose or glycine, to assist intestinal Na and thereby 
water absorption through sodium-glucose linked trans-
port proteins (SGLT); (3) alkalinizing agents to correct 
acidemia or metabolic acidosis frequently encountered 
in diarrheic calves; and (4) to provide energy to reduce 
negative energy balance (Smith, 2009). Glucose is used 
as an ingredient in most commercial ORS to improve 
intestinal Na and water absorption and to provide read-
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ily available energy for the organism. In contrast, oral 
glucose administration is not known to have any effect 
on acid-base homeostasis. The strong ion theory pro-
vides theoretical support for the hypothesis that orally 
administered glucose could indirectly affect acid-base 
homeostasis by facilitating intestinal Na absorption 
(Stewart, 1978). The strong ion theory is based on the 
concept that acid-base homeostasis of the extracellu-
lar space depends on the equilibrium between strong 
cations and strong anions, with cations, such as Na 
or potassium, having an alkalinizing effect and strong 
anions, such as chloride, having an acidifying effect 
(Stewart, 1978). Increasing the availability of Na in the 
extracellular space by enhancing Na absorption from 
the gut through the combination of glucose with Na 
in an ORS could potentiate the alkalinizing capacity 
of Na, according to the strong ion theory. Accordingly, 
we hypothesized that the combination of NaHCO3 with 
glucose in an ORS would improve the alkalinizing effect 
of NaHCO3 when compared with an ORS containing 
NaHCO3 alone. The objective of the present study was 
to compare the alkalinizing effect of NaHCO3 after oral 
administration with and without glucose in euhydrated 
neonatal calves.
MATERIALS AND METHODS
All methods were approved by the Animal Care and 
Use Committee, Berlin, Germany (Permit #0384/10).
Animal Housing and Feeding
Nine healthy male Holstein-Friesian calves were ob-
tained from a commercial dairy farm between 7 and 
14 d of age. Results of this study focusing on the ef-
fect of orally applied electrolyte solutions on plasma 
potassium concentration in neonatal dairy calves have 
been published previously (Grünberg et al., 2011b). 
Calves were kept unrestrained in groups of 2 in stalls 
bedded on straw in a climate-controlled environment. 
All animals were allowed a 6- to 8-d acclimatization 
period, during which their health status was monitored. 
A commercial CN-based milk replacer (Sprayfro Sprint, 
Sloten, Diepholz, Germany) with 22.5% CP, 16% crude 
fat, 0.1% crude fiber, and 7.0% crude ash was fed twice 
daily (150 g of milk replacer per liter of water; 60 mL of 
solution per kilogram of BW; pH = 6.5; temperature = 
38°C) in a nipple bucket (equivalent to approximately 
900 g of milk replacer per day). Calves had access to 
fresh water ad libitum, except for an 8-h period follow-
ing each experimental treatment. All calves were com-
pletely physically examined 12 to 24 h before the start 
of the first treatment and were instrumented as fol-
lows. A 16 gauge, 83-mm catheter (Angiocath, Becton 
Dickinson, Franklin Lakes, NJ) was aseptically fitted 
in a jugular vein and an aortic catheter was aseptically 
placed in the abdominal aorta under ultarsonographic 
control as described by Offinger et al. (2011). A urine 
collection bag with a connection port to attach tubing 
for urine collection was glued onto the hair around the 
preputium of the calves. Catheters and urine collec-
tion bags remained in place from d 5 until the end 
of the study. Venous and aortic catheterization was 
performed after sedation with xylazine (0.2 mg/kg of 
BW i.m.), aseptic preparation of the skin, and injection 
of 1 mL of procaine 4% into and under the skin at the 
site of catheter placement. For venous catheterization, 
a small stab incision through the skin was made with 
a scalpel to facilitate catheter placement. The catheter 
was placed into the vein, connected to an extension 
set (Discofix C-3, 10 cm, Braun Melsungen AG, Mel-
sungen, Germany), and secured in place with suture 
material. At the same time of venous catheterization, 
an aortic catheter was placed in the left paraveterebral 
area between the third and fourth lumbar transversal 
process. For aortic catheter placement, the skin was 
prepierced with a 12 gauge needle. A 10-cm, 12 gauge 
needle was then advanced through the prepierced skin 
and the lumbar musculature to penetrate through the 
transversal ligament between the third and the fourth 
lumbar vertebrae. Using a 7.5-MHz linear transducer 
placed in the left flank, the needle was forwarded un-
der visual control into the aorta. Once blood gushed 
through the 12 gauge needle, sterile polyamide tubing 
(4 French, 1.37 mm outer diameter, 40 cm length; 
Walter Veterinärinstrumente e.K., Baruth, Germany) 
threaded over a Teflon-coated J-tipped guide wire (J-
wire, Teflon coated, 0.81 mm, 150 cm length; Walter 
Veterinärinstrumente e.K.) was inserted into the aorta 
through the needle. The guide wire and the polyamide 
tubing were then advanced approximately 10 cm into 
the abdominal aorta in the caudal direction. The cor-
rect position of the polyamide tubing was confirmed ul-
trasonographically before removing the guide wire and 
the needle. The tubing was then secured in place with 
tape and suture material. Both catheters were flushed 
with heparinized 0.9% NaCl solution (40 U of heparin/
mL) immediately before and after each blood collection 
and every 8 to 12 h while animals were not on study.
Experimental Protocol
Experimental treatments were administered between 
15 and 24 d of age and at least 12 h after the last 
feeding. Calves on trial were restrained with a fence 
placed in the stall in such manner that they could lie 
and stand easily but could not turn. Treatment order 
was assigned randomly (by drawing cards) for each in-
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dividual animal with a washout period of 48 h between 
treatments. On each trial day, calves were tube-fed 
between 0800 and 0815 h with one of the following test 
solutions at approximately 38°C: 25.2 g of NaHCO3 in 2 
L of tap water (NaBic; 150 mmol/L); 118 g of glucose 
monohydrate in 2 L of tap water (Gluc; 300 mmol/L); 
and 25.2 g of NaHCO3 plus 118 g of glucose in 2 L of 
tap water (Combi). The solutions of group NaBic and 
Gluc were formulated to be isotonic (300 mOsmol/L); 
the test solution of group Combi was of double tonicity 
(600 mOsmol/L), but formulated to match the Na to 
glucose ratio of 1:2 on the molar basis recommended for 
ORS for calves (Smith, 2009). Tube feeding was chosen 
over voluntary intake to standardize the ingestion time 
of the test solutions, as different palatability of salt and 
glucose solution was likely to affect ingestion time.
Venous and arterial blood samples were obtained from 
the jugular and aortic catheters at 0 min (immediately 
before tube feeding) as well as 30, 60, 90, 120, 150, 180, 
210, 240, 300, 360, 420, and 480 min after tube feeding. 
Blood for blood gas analysis was collected anaerobically 
into heparinized 1-mL plastic syringes that were im-
mediately capped and kept at room temperature until 
analyzed. Blood gas analysis was performed within 10 
min of collection. Blood for biochemical analysis was 
collected into 10-mL tubes containing Li-heparin as an 
anticoagulant and centrifuged within 10 min at 1,500 × 
g for 15 min at room temperature. Plasma was harvested 
and stored at −24°C until analyzed. Immediately after 
administration of the test solution, tubing connected 
to a 3-L collection vial was attached to the connect-
ing port of the urine collection bag to allow volumetric 
urine collection for a period of 8 h after the start of 
treatment. The collection vial contained mineral oil to 
minimize air exposure of urine, which would alter urine 
pH. At the end of the 8-h study period, the volume 
of collected urine was determined and a urine sample 
was obtained anaerobically after thorough mixing. The 
sample was then transferred into two 5-mL vials that 
were completely filled and immediately capped to mini-
mize exposure to air. One tube was placed in a water 
bath at 38°C and the pH was measured within 15 min. 
Tubes were then stored at −21°C for further analyzes.
Plasma samples were assayed for concentration of 
Na (flame atomic absorption spectrometry), K (flame 
atomic absorption spectrometry), chloride (indirect ion 
selective electrode system), glucose (hexokinase), and 
total protein (TP; biuret). An automated chemistry 
analyzer (Cobas Mira Plus, Roche, Basel, Switzerland) 
was used for the plasma biochemical analysis; flame 
atomic absorption spectrometry was conducted on a 
Solaar M6 spectrometer (Thermo Fisher Scientific, 
Schwerte, Germany). Blood gas analysis was performed 
on an automated blood gas analyzer (Radiometer 
AVL5, Brønshøj, Denmark). Measured values for blood 
pH, partial pressure of CO2 (Pco2), and partial pressure 
of O2 were corrected for rectal temperature and used to 
calculate the actual venous blood (vABC) and stan-
dard venous blood HCO3 (vSBC; concentration of the 
bicarbonate ion in blood calculated for a standard PCO2 
= 5.33 kPa) concentration using standard equations 
(Burnett et al., 1995). Urine was analyzed for urine Na 
and glucose as described for plasma. Total excretion of 
Na and glucose was calculated from the concentration 
of these compounds and the determined urine volume. 
Urine osmolality was determined by freezing-point 
depression (Micro Osmette, Precision Systems Inc., 
Natick, MA). Urinary net base excretion (NBE) and 
ammonium concentration were determined by titration 
as described elsewhere (Chan, 1972; Constable et al., 
2009; Grünberg et al., 2011a). Briefly, previously frozen 
urine was thawed at room temperature, acidified by the 
addition of a fixed volume of 1 N of HCl and heated to 
a slow boil for at least 2 min to expel CO2. Urine was 
then back-titrated with 0.1 N of NaOH to the pH of 
7.4. Eight percent formaldehyde was then added and 
the volume of 0.1 NaOH needed to back-titrate the 
urine sample to a pH of 7.4 was determined.
To crudely estimate the volume changes of extracel-
lular space that might have occurred after treatment, 
changes in plasma volume at each time point i relative 
to the beginning of the experiment (T0) were extrapo-
lated from the changes in [TP] as follows: VolDiffi (%) 
= ([TP0] − [TPi]) × 100/[TPi] (Nouri and Constable, 
2006).
The strong ion difference (SID) was calculated from 
the plasma concentrations of Na, K, and Cl as follows: 
SID3 (mEq/L) = {([Na] + [K]) − [Cl]}. Anion Gap 
(AG) in mEq/L was calculated from the calculated 
value for [vABC] (Constable, 1999) as AG = ([Na] 
+ [K]) − ([Cl] + [vABC]). Strong ion gap (SIG; in 
mEq/L) was calculated as SIG = [TP] × {0.343/(1 
+ 107.08−pH)} − AG, where [TP] was measured in g/L 
(Constable et al., 2005).
To determine the kinetics of glucose absorption, the 
maximal glucose concentration (Cmax) and the time to 
maximal glucose concentration (Tmax) were obtained 
from the plasma glucose concentration-time curves The 
increment of concentration of glucose relative to T0 
was determined for each time point i using the equa-
tion GlucDiffi = [glucosei] − [glucose0]. Furthermore, 
the maximal increment of the glucose concentration 
(Cmax-GlucDiff) and the time to maximal increment of the 
glucose concentration (Tmax-GlucDiff) were determined for 
each treatment. In a similar manner, the changes in 
concentration for each time point relative to T0 were 
determined for Na (NaDiffi), vSBC (vSBCDiffi), and 
SID (SID3Diffi). The change of the plasma [glucose] 
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and plasma [Na] were also corrected for plasma volume 
changes relative to T0 using the equation
GlucDiffVoli (mmol/L) = GlucDiffi  
+ (GlucDiffi × VolDiffi/100).
The area under curve (AUC) for plasma [glucose], 
[Na], and VolDiff increment − time for the first 4 h after 
treatment (AUCGlucDiff-240, AUCHCO3Diff-240, AUCBEDiff-240), 
as well as the AUC of the change of plasma vSBC rela-
tive to T0 for the entire study period (AUCvSBCDiff-480), 
were calculated using the trapezoidal rule.
Statistical Analysis
Data are expressed as mean ± SD or as median and 
interquartile range. Values determined at P < 0.05 were 
considered to be significant. Values were log-transformed 
when necessary to achieve a normal distribution. Re-
peated measures ANOVA was used to detect differences 
in measured parameters between treatment groups and 
over time using PROC MIXED (SAS 9.2, SAS Institute 
Inc., Cary, NC). Bonferroni-adjusted P-values were 
used to assess differences over time whenever the F test 
was significant. A power analysis was conducted using 
PROC POWER to determine the smallest effect size 
on vSBC, vSBCDiff, [glucose], and GlucDiff detectable 
with α = 0.05, Power = 0.8, and n = 9.
RESULTS
Acid-Base Homeostasis
Venous blood pH and the difference of vSBC relative 
to T0 (vSBCDiff) over time and stratified by treatment 
group are presented in Figure 1. Actual venous HCO3, 
vSBC, arterial blood pH, and arterial Pco2 are presented 
in Table 1, stratified by treatment and sampling time. 
Treatment effects were identified for venous blood pH 
(P < 0.0001), vABC (P = 0.001), vSBC (P = 0.005), 
and arterial pH (P = 0.0048), with group Gluc differing 
significantly from groups NaBic and Combi. No differ-
ences were found between groups NaBic and Combi. 
Differences between the latter 2 groups were identified 
only for vSBCDiffi (Figure 1). The AUCVSBC480 was 1,203 
± 472 mmol/min per L, −195 ± 654 mmol/min per L, 
and 1,767 ± 862 mmol/minper L for groups NaBic, 
Gluc, and Combi, respectively. Values determined for 
group Gluc were significantly below those calculated 
for groups NaBic and Combi. No difference was identi-
fied between groups NaBic and Combi. A treatment 
effect was not determined on AG, SIG, or SID.
Plasma Na, Glucose, and Plasma Volume Changes
The plasma Na concentration-time curves stratified 
by treatments are presented in Figure 2. Treatment and 
time effects were identified on the plasma [Na], with 
group Gluc differing significantly from groups NaBic 
and Combi. Changes in plasma [Na] over time were not 
significant in any of the treatment groups when apply-
ing a Bonferroni correction. The AUCDiffNa240 was 255.0 
± 411.2 mmol/min per L, −338.3 ± 548.4 mmol/min 
per L, and −8.0 ± 482.6 mmol/min per L for groups 
NaBic, Gluc, and Combi, respectively. No treatment 
effect on AUCDiffNa240 was observed. Volume-corrected 
plasma [Na] in group NaBic were above concentrations 
calculated for group Gluc from 90 to 300 min post-
treatment (Figure 3). Volume-corrected plasma [Na] 
in group Combi ranged between values calculated for 
group NaBic and Gluc. Differences between Combi and 
NaBic were significant at only 1 time point (Figure 3).
Plasma glucose concentration-time curves had 
similar slopes and amplitudes in groups Gluc and 
Combi, whereas, plasma [glucose] remained unchanged 
throughout the study period in group NaBic, as ex-
pected (Grünberg et al., 2011b; Figure 4). Treatment 
and time effects were identified on plasma [glucose], 
with group NaBic differing significantly from groups 
Gluc and Combi. A treatment effect was also deter-
mined on Cmax-GlucDiff, Tmax-GlucDiff, and AUCGlucDiff 240, 
with group NaBic differing from groups Gluc and 
Combi. No differences between groups Gluc and Combi 
were found for any of those parameters. The Cmax and 
Tmax for plasma [glucose] were 5.2 ± 1.5 mmol/L and 
83 ± 29 min, respectively, in group Gluc, and 5.4 ± 
1.7 mmol/L and 64 ± 11 min, respectively, in group 
Combi. Differences between these 2 groups were not 
significant. The AUCGlucDiff240 was −125.9 ± 110.0 
mmol/min per L, 539.9 ± 254.6 mmol/min per L and 
513.7 ± 220.1 mmol/min per L for NaBic, Gluc, and 
Combi, respectively. A treatment effect was identified, 
with values calculated for group NaBic being signifi-
cantly lower than those calculated for groups Gluc and 
Combi. Volume-corrected changes for plasma [Glucose] 
in group NaBic were below values measured in groups 
Gluc and Combi from 30 to 240 min after treatment. 
No difference was determined between group Gluc and 
Combi at any sampling time.
Plasma volume, as estimated from the changes in 
plasma [TP], was significantly increased relative to T0 
from 60 to 150 min after treatment,, but no treatment 
effect was determined (Grünberg et al. 2011b). The 
AUC of plasma volume expansion during the first 4 h 
after treatment (AUCVolDiff240) was 920.4 ± 653.8% per 
min, 264.0 ± 389.7% per min, and 730.5 ± 802.3% per 
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Figure 1. Mean ± SD of venous blood pH (upper panel) and change of venous standard bicarbonate concentration of blood [SBC] relative to 
the beginning of the experiment (T0) for treatment groups: 25.2 g of NaHCO3 in 2 L of tap water (NaBic; solid line); 118 g of glucose monohy-
drate in 2 L of tap water (Gluc; dashed line); and 25.2 g of NaHCO3 and 118 g of glucose monohydrate in 2 L of tap water (Combi; dash-dotted 
line). Treatment was administered at T0. Values with different capital letters differ significantly between groups (P < 0.05). Values marked with 
an asterisk differed significantly (P < 0.05, Bonferroni corrected) from T0 values.
3900 GRÜNBERG ET AL.
Journal of Dairy Science Vol. 96 No. 6, 2013
min for groups NaBic, Gluc, and Combi, respectively. 
The treatment effect was not significant.
Urine Volume, pH, Renal Sodium,  
and Net Base Excretion
Urine volume production over 8 h following experi-
mental treatment was similar in all groups, but showed 
broad variability between animals (Table 2). Urine pH, 
NBE, total renal Na excretion, and urine osmolality 
were significantly higher in groups NaBic and Combi 
compared with Gluc (Table 2). Numerical differences 
between NaBic and Combi for NBE did not reach sig-
nificance level (Table 2).
Sample Size and Statistical Power
The power analysis performed to determine the small-
est detectable effect size on vSBC and SBCDiff as well 
as [glucose] and GlucDiff, with α = 0.05, Power = 0.8, 
and n = 9, indicated that the sample size was sufficient 
to identify significant differences between groups of 1.6 
mmol/L and 1.0 mmol/L for vSBC and vSBCDiff , re-
spectively. Similarly, the smallest detectable effect size 
Table 1. Mean ± SD of venous actual bicarbonate concentration (vABC), venous standard bicarbonate 
concentration (vSBC), arterial pH (apH), and arterial partial pressure of CO2 (apCO2) at different sampling 









0 NaBic 30.8 ± 3.4a 28.2 ± 2.9a 7.42 ± 0.03a 5.9 ± 0.4a
Gluc 29.3 ± 1.7a 27.7 ± 1.6a 7.42 ± 0.02a 6.2 ± 0.6a
Combi 29.4 ± 2.2a 27.0 ± 1.6a 7.40 ± 0.02a 6.2 ± 0.5a
30 NaBic 30.2 ± 4.0a 27.9 ± 3.1a 7.42 ± 0.05a 6.3 ± 0.2a
Gluc 29.6 ± 1.8a 27.3 ± 1.8a 7.41 ± 0.01a 6.3 ± 0.5a
Combi 30.3 ± 1.9a 28.3 ± 1.6a* 7.41 ± 0.01a 6.2 ± 0.7a
60 NaBic 32.1 ± 4.0a 29.8 ± 3.3a* 7.42 ± 0.03a 6.4 ± 0.4a
Gluc 29.6 ± 2.3b 27.4 ± 2.2b 7.42 ± 0.02a 6.0 ± 0.2a
Combi 31.8 ± 2.6ab* 29.3 ± 2.2ab* 7.44 ± 0.04a* 6.2 ± 0.9a
90 NaBic 33.0 ± 3.8a* 30.7 ± 3.2a* 7.43 ± 0.03ab 6.5 ± 0.5a
Gluc 29.8 ± 2.4b 27.6 ± 2.1b 7.41 ± 0.02b 6.2 ± 0.3a
Combi 32.1 ± 2.8a* 29.9 ± 2.3a* 7.45 ± 0.04a 6.3 ± 0.9a
120 NaBic 34.3 ± 3.2a* 31.6 ± 2.7a* 7.44 ± 0.03a 6.6 ± 0.5a
Gluc 28.8 ± 2.4b 26.4 ± 1.7b 7.41 ± 0.03a 6.2 ± 0.7a
Combi 33.6 ± 2.7a* 30.4 ± 2.3a* 7.43 ± 0.02a 6.6 ± 0.4a
150 NaBic 33.9 ± 3.3a* 30.8 ± 2.6a* 7.44 ± 0.02a 6.3 ± 0.5a
Gluc 29.8 ± 1.9b 27.3 ± 1.5b 7.40 ± 0.02b 6.3 ± 0.4a
Combi 34.0 ± 3.0a* 30.8 ± 2.2a* 7.44 ± 0.03a 6.4 ± 0.8a
180 NaBic 33.9 ± 3.4a* 31.1 ± 2.6a* 7.44 ± 0.01a 6.5 ± 0.7a
Gluc 29.8 ± 1.7b 27.1 ± 1.6b 7.41 ± 0.02b 6.2 ± 0.4a
Combi 33.6 ± 3.0a* 30.9 ± 2.5a* 7.43 ± 0.01ab 6.5 ± 0.8a
210 NaBic 33.0 ± 3.3a 30.7 ± 2.8a* 7.44 ± 0.02a 6.6 ± 0.5a
Gluc 29.4 ± 1.7b 27.0 ± 1.9b 7.43 ± 0.03a 5.7 ± 0.6b
Combi 34.0 ± 2.9a* 31.2 ± 2.5a* 7.43 ± 0.02a 6.8 ± 0.6a
240 NaBic 33.7 ± 3.6a* 30.9 ± 2.6a* 7.44 ± 0.02a 6.5 ± 0.5a
Gluc 29.4 ± 2.8b 27.2 ± 1.8b 7.40 ± 0.02b 6.2 ± 0.4a
Combi 34.7 ± 2.7a* 31.4 ± 1.9a* 7.44 ± 0.01a 6.3 ± 0.6a
300 NaBic 34.6 ± 3.6a* 31.7 ± 2.5a* 7.45 ± 0.03a 6.4 ± 0.5a
Gluc 30.1 ± 2.3b 27.6 ± 1.6b 7.41 ± 0.03b 6.2 ± 0.6a
Combi 34.6 ± 2.7a * 31.3 ± 1.9a* 7.45 ± 0.02a 6.5 ± 0.6a
360 NaBic 33.8 ± 3.0a 31.0 ± 2.2a* 7.45 ± 0.02a 6.4 ± 0.5a
Gluc 29.5 ± 2.6b 27.2 ± 1.7b 7.41 ± 0.02b 6.2 ± 0.5a
Combi 34.2 ± 3.1a* 31.1 ± 2.4a* 7.44 ± 0.03ab 6.7 ± 0.4a
420 NaBic 34.3 ± 3.1a* 31.1 ± 2.6a* 7.44 ± 0.02a 6.4 ± 0.4a
Gluc 29.9 ± 2.0b 27.2 ± 1.8b 7.41 ± 0.02a 6.1 ± 0.6a
Combi 34.6 ± 3.1a* 31.7 ± 2.4a* 7.44 ± 0.02a 6.6 ± 0.6a
480 NaBic 33.9 ± 2.9a* 32.1 ± 2.0a* 7.43 ± 0.02a 6.6 ± 0.4a
Gluc 29.3 ± 3.2b 27.2 ± 2.4b 7.42 ± 0.04a 5.8 ± 0.4a
Combi 34.1 ± 2.3a* 31.1 ± 2.5a* 7.44 ± 0.01a 6.5 ± 0.4a
a,bValues from the same sampling time with different letters are significantly different (P < 0.05). 
1NaBic = 25.2 g of NaHCO3 in 2 L of tap water; Gluc = 118 g of glucose monohydrate in 2 L of tap water; 
Combi = 25.2 g of NaHCO3 and 118 g of glucose monohydrate in 2 L of tap water.
*Values are significantly different from values obtained at the beginning of the experiment in the same group 
(P < 0.05, bonferroni corrected).
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for plasma [glucose] was 2.5 mmol/L and 2.0 mmol/L 
for [glucose] and GlucDiff, respectively.
DISCUSSION
The objective of the current study was to determine 
if the combination of NaHCO3 and glucose, when ad-
ministered orally to neonatal calves, potentiates the 
alkalinizing effect of NaHCO3 by facilitating enteral Na 
uptake through SGLT. This hypothesis was based on 
the strong ion theory, suggesting that enhanced enteral 
Na absorption in the presence of glucose would result 
in higher cation content with an alkalinizing effect in 
the extracellular space (Stewart, 1978). In the cur-
rent study, we were only able to identify very subtle 
effects of the combination of NaHCO3 with glucose on 
acid-base homeostasis when compared with the oral 
administration of NaHCO3 alone. The observed effect 
of less than 2 mmol/L in vSBCDiff between animals 
receiving oral NaHCO3, with and without glucose, was 
clearly below what was expected from SGLT, which is 
considered a major route of intestinal Na and glucose 
absorption based on our hypothesis. The results of the 
power analysis indicate that the sample size provided 
sufficient power to identify group differences of at least 
1 mmol/L for vSBCDiff, which is approximately equiva-
lent to the precision of the results provided by standard 
blood gas analyzers. Interestingly, we not only failed in 
identifying any measurable effect of orally administered 
glucose on the intestinal uptake of Na or water, but also 
did not detect any effect of orally administered Na on 
the intestinal absorption kinetics of glucose.
Values for the threshold concentration for Na in the 
small intestinal lumen in different species above which 
net Na absorption from the gut can be expected to 
range from 50 to 120 mmol/L, as reported in the lit-
erature (Aperia et al., 1983; Elliott et al., 1989; Elliott 
et al., 1991; Gisolfi et al., 1992). Therefore, it appears 
reasonable to assume that intestinal net Na absorption 
occurred after oral administration of solutions with a 
[Na] of 150 mmol/L, as was the case in groups NaBic 
and Combi. A comparison of the concentration-time 
curves of actual and volume-corrected plasma [Na], 
renal Na, and NBE excretions during the first 8 h after 
treatment between animals having received NaHCO3 
with and without glucose, did not reveal any net effect 
of glucose on intestinal Na absorption after adminis-
tration of NaHCO3. Similar plasma volume expansion-
Figure 2. Mean ± SD plasma Na concentration for treatment groups: 25.2 g of NaHCO3 in 2 L of tap water (NaBic; solid line); 118 g of 
glucose monohydrate in 2 L of tap water (Gluc; dashed line); and 25.2 g of NaHCO3 and 118 g of glucose monohydrate in 2 L of tap water 
(Combi; dash-dotted line). Treatment was administered at the beginning of the experiment (T0). Values with different letters differ significantly 
between groups (P < 0.05).
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time curves and urine volumes in all groups further 
suggests that net water absorption was not measurably 
enhanced by the combination of NaHCO3 with glucose.
The extent of intestinal Na and water absorption is 
dictated by the equilibrium between several mecha-
nisms: electrogenic Na absorption, solvent drag mov-
ing Na along with water, the coupled transport of Na 
with glucose and other organic compounds, the coupled 
transport with Cl, and the Na-H-exchange mechanism. 
(Elliott et al., 1989; Gisolfi et al., 1992). Of those 
mechanisms, Na transport through SGLT and solvent 
drag are presumably affected by the combination of 
NaHCO3 with glucose. Whereas the combination of 
NaHCO3 with glucose is considered to increase enteral 
net Na absorption by providing both substrates for 
SGLT, solvent drag of water into the intestinal lumen 
after ingestion of a hypertonic solution containing 
NaHCO3 and glucose likely hampers net Na and wa-
ter absorption when compared with animals receiving 
NaHCO3 alone (Phillips and Summersk, 1967; Aperia 
et al., 1983; Pfeiffer et al., 1998). The results of this 
study suggest that if intestinal Na absorption through 
SGLT was enhanced in animals receiving hypertonic 
ORS containing NaHCO3 and glucose, this effect was 
most likely antagonized by the effect of hypertonicity 
dragging water from the intercellular space into the gut 
lumen.
Similar glucose concentration-time curves in animals 
having received oral glucose with and without NaHCO3 
indicate that the efficacy of intestinal glucose absorp-
tion in this study did not depend on oral Na supple-
mentation. Intestinal glucose absorption through SGLT 
is currently perceived to be the predominant pathway 
of intestinal glucose uptake (Wood et al., 2000; Banks 
and Farthing, 2002). Sodium-glucose linked trans-
port occurs at a fixed stochiometric ratio of 2 Na to 
1 glucose molecule, and is therefore dependent on the 
availability of Na in the intestinal lumen in sufficient 
quantities (Turk et al., 2000; Wright et al., 2011). As 
mentioned previously, the direction and extent of the 
Na flux across the small intestinal mucosa, and there-
fore the availability of Na in the small intestinal lumen, 
strongly depends on the electrochemical gradient for 
Na between gut lumen and subepithelial space (Elliott 
Figure 3. Mean ± SD change in plasma Na concentration relative to baseline concentration at the beginning of the experiment (T0) cor-
rected for changes in plasma volume relative to T0 for treatment groups: 25.2 g of NaHCO3 in 2 L of tap water (NaBic; solid line); 118 g of 
glucose monohydrate in 2 L of tap water (Gluc; dashed line); and 25.2 g of NaHCO3 and 118 g of glucose monohydrate in 2 L of tap water 
(Combi; dash-dotted line). Treatment was administered at T0. Values with different capital letters differ significantly between groups (P < 0.05).
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et al., 1989; Gisolfi et al., 1992). Administration of a 
test solution containing glucose but no Na is likely to 
trigger increased Na secretion into the small intestinal 
lumen along a steeper electrochemical gradient, thereby 
providing Na for SGLT (Spiller et al., 1987). The initial 
ratio between glucose and Na would not only be altered 
by the electrochemical gradient but also by the tonicity 
created in the gut lumen, which would determine direc-
tion and degree of the drag of water and Na across the 
small intestinal mucosa (Aperia et al., 1983; Pfeiffer 
et al., 1998). This effect potentially explains similar 
glucose concentration-time curves in animals having 
received glucose with and without NaHCO3, but would 
also question the importance of formulating ORS with 
a specific ratio of glucose to Na to optimize enteral 
Na absorption. An earlier study conducted in humans 
found that net water absorption was not dependent on 
the ratio between Na and glucose in the ORS, a finding 
that was explained by rapid changes in luminal [Na] 
and [glucose] as ORS passed through the small intes-
tinal tract (Gisolfi et al., 1992). Similar results were 
reported in horses, where the addition of glucose to 
Figure 4. Mean ± SD of the change in plasma glucose concentration relative to baseline concentration at the beginning of the experiment 
(T0) for treatment groups: 25.2 g of NaHCO3 in 2 L of tap water (NaBic; solid line); 118 g of glucose monohydrate in 2 L of tap water (Gluc; 
dashed line); and 25.2 g of NaHCO3 and 118 g of glucose monohydrate in 2 L of tap water (Combi; dash-dotted line). Treatment was adminis-
tered at T0. Values marked with an asterisk differ significantly from values obtained in all other groups at the same sampling time (P < 0.05).
Table 2. Mean ± SD or median and interquartile range of urine variables stratified by treatment group1 
Parameter NaBic Gluc Combi
Urine volume (mL/8 h) 1,270 ± 762 1,361 ± 562 1,346 ± 698
Urine pH 7.54 ± 0.61a 6.69 ± 0.32b 7.42 ± 0.53a
Urine net base excretion(mmol/L) 61.2 ± 46.9 8.5 ± 6.2 38.6 ± 30.7
Total renal Na excretion (mmol/8 h) 102.2 ± 21.2a 26.6 ± 12.0b 108.6 ± 63.6a
Total renal glucose excretion (mmol/8 h) 0.0 [0.0–0.0] 0.0 [0.0–0.4] 0.1 [0.0–0.7]
Urine osmolarity (mOsmol/L) 281 ± 149a 115 ± 43b 253 ± 53a
a,bValues with different letters in one line are significantly different (P < 0.05)
1NaBic = 25.2 g of NaHCO3 in 2 L of tap water; Gluc = 118 g of glucose monohydrate in 2 L of tap water; Combi = 25.2 g of NaHCO3 and 118 
g of glucose monohydrate in 2 L of tap water.
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ORS containing Na had no effect on the intestinal fluid 
uptake in experimentally dehydrated adult horses (Sosa 
León et al., 1995).
Although the importance of SGLT for intestinal glu-
cose absorption is well established, evidence for another 
quantitatively relevant, Na-independent mechanism for 
enteral glucose absorption has been reported (Gisolfi et 
al., 1992). Rapid and quantitatively important trans-
location of GLUT2 transport proteins onto the jejunal 
brush border membrane as glucose content in the small 
intestinal lumen increased has been documented in 
several studies conducted in rats (Kellett and Helliwell, 
2000). This exteriorization of GLUT2 was associated 
with an important increase in Na-independent glucose 
absorption from the jejunum that could be inhibited by 
the administration of phlorizine (Kellett and Helliwell, 
2000). A similar GLUT2-dependent upregulation of 
glucose absorption has not yet been identified in rumi-
nants, but would certainly explain the identical glucose 
concentration-time curves after oral administration of 
the same amount of glucose with and without Na.
In the present study, ORS with markedly different 
osmolarity were compared with each other. We opted 
not to equilibrate test solutions Gluc and NaBic to the 
same osmolarity as Combi to avoid the use of another 
osmotically active compound that would likely have 
confounded the results by either altering the SID of 
the test solution or the osmolarity of the intestinal 
content by presenting different absorption kinetics 
than glucose. Thus, the benefits of equilibrating all test 
solutions to the same osmolarity were considered to be 
limited. Osmolarities of the test solutions used in this 
study ranged between 300 and 600 mOsmol/L and, 
therefore, were in the range of osmolarities of common 
commercial ORS for calves (Smith, 2009).
Changes in body mass during the study period have 
been used in earlier studies with parenteral fluid ad-
ministration to estimate water retention (Fielding et 
al., 2008). For the present study, this parameter was 
considered unsuitable because oral administration of 
solutions with markedly different osmolarities were 
administered orally. Differences in osmolarity not only 
have the potential to affect abomasal emptying time, 
and thereby the transit time of ingesta through the gas-
trointestinal tract, but also the fecal water content, and 
thereby the mass of the gastrointestinal content. Dif-
ferences in body mass changes between groups in this 
study would not have allowed us to draw conclusions 
on differences in intestinal water absorption between 
groups.
The effect of tonicity on the efficacy of an ORS is 
an issue of great controversy in the human and veteri-
nary literature (Rao, 2004; Michell, 2005). In human 
medicine, general consensus exists that hypotonic ORS 
are more suitable to treat dehydration than isotonic 
ORS, and that hypertonic ORS are contraindicated in 
dehydrated patients. Concerns about the use of iso- or 
hypertonic electrolyte solutions in humans are related 
to incidental reports of hypernatremia attributed to the 
use of isotonic oral electrolyte solutions, as well as to 
the potential risk for osmotic diarrhea (Farthing, 1994). 
Indeed, a number intestinal perfusion and several ran-
domized controlled field studies conducted in humans 
and other species revealed that ORS with lower Na 
content and lower osmolarity improved intestinal net 
water and Na absorption and reduced morbidity time 
and number of treatment failures requiring parenteral 
fluid administration (Duggan et al., 2004; Atia and Bu-
chman, 2009). Conversely, due to concerns with inad-
equate Na and energy supply in diarrheic calves the use 
of hypertonic ORS in calves has intensively been stud-
ied in the last decades and strongly encouraged (Levy 
et al., 1990; Brooks et al., 1996; Constable et al., 2001; 
Sen et al., 2006; Smith, 2009). In contrast to concerns 
raised in human medicine, several studies showed that 
hypertonic ORS administered to dehydrated diarrheic 
calves neither exacerbated dehydration nor caused os-
motic diarrhea or hypernatremia, but provided more 
energy through higher glucose absorption (Levy et al., 
1990; Brooks et al., 1996; Constable et al., 2001; Sen 
et al., 2006). However, similar to the findings reported 
here, studies comparing hypertonic and isotonic ORS 
containing Na and glucose administered to calves failed 
to identify a positive effect of hypertonic solutions on 
hydration status (Levy et al., 1990; Brooks et al., 1996; 
Constable et al., 2001). The absence of negative ef-
fects on hydration status or intestinal water absorption 
when using hypertonic ORS is consistent with results 
presented in this study and has been explained by a 
countercurrent mechanism hypothesized to function 
in the small intestinal mucosa. Similar to the mecha-
nism described in the renal tubuli, this countercurrent 
mechanism is believed to allow absorption of hyper-
tonic fluid with an osmolarity of up to 600 mOsmol/L 
from the gut lumen (Jodal and Lundgren, 1986; Smith, 
2009).
When formulating the test solutions used in this 
study, care was taken not to exceed the expected ab-
sorptive capacity for glucose of the gastrointestinal 
tract to prevent osmotic diarrhea. The upper limit for 
glucose content in ORS for calves was estimated to be 
around 3.6 g/kg of BW, above which unabsorbed and 
osmotically active glucose may carry over into the large 
intestine (Sen et al., 2006). In the present study 118 g of 
glucose were administered per application in group Gluc 
and Combi, equivalent to approximately 2 g/kg of BW.
In earlier studies, the plasma glucose concentration-
time curve was used to estimate abomasal emptying 
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rates in neonatal calves after administration of ORS 
with varying tonicity. In these studies, a decreased ab-
omasal emptying rate in healthy neonatal calves was 
determined when feeding ORS with 600 mmol/L of glu-
cose compared with solutions containing 300 mmol/L 
of glucose (Sen et al., 2006). This delay in abomasal 
emptying was associated with a delay in time to reach 
maximal blood glucose concentrations (TmaxGluc). The 
results presented here show identical glucose concen-
tration time curves and thus identical times to reach 
maximal blood glucose concentrations after administra-
tion of solutions containing the same amount of glucose 
but markedly different osmolarity. This discrepancy 
suggests the delayed abomasal emptying observed by 
Sen et al. (2006) may not be due to increased osmolar-
ity, but rather to the increased glucose load itself or 
the ensuing higher caloric content as it is the case in 
other species (Moran et al., 1999). Because the plasma 
glucose concentration measured after oral glucose ad-
ministration is influenced in a nonlinear manner by a 
number or regulatory mechanisms, such as the release 
of insulin and renal glucose excretion, the plasma glu-
cose concentration-time curve can only be considered 
a crude parameter to estimate the abomasal emptying 
rate in calves.
An indirect ion selective electrode (ISE) system was 
used to determine the plasma [Cl], which was then used 
to calculate SID and AG. Measurement of electrolyte 
concentrations with indirect ISE systems have been 
reported to be affected by the plasma protein concen-
tration, with decreasing plasma protein concentrations, 
as observed in the present study, resulting in artificially 
increased plasma electrolyte concentrations (Dimeski 
and Barnett, 2005). Therefore, it is possible that a 
mild artificial decrease over time in the SID and AG 
calculated from plasma [Cl] may have occurred in our 
data set. The SID and AG calculated from artificially 
increased plasma [Cl] may have resulted in a mild ar-
tificial decrease of these parameters, thereby occulting 
a possibly developing strong ion alkalosis, as it would 
be expected after administration of sodium bicarbon-
ate. For this reason in this and similar studies, chloride 
analysis with direct ISE systems would have been pref-
erable over indirect ISE systems.
Although the treatment with ORS is relevant for 
dehydrated and acidemic diarrheic calves, we opted 
to conduct this study on clinically healthy and euhy-
drated calves. The efficacy of ORS to treat dehydration 
in calves and other species has largely been attributed 
to the function of SGLT, which in most cases is not 
or is only partially affected by enteral disease (Naylor, 
1999). Results from this study can potentially contrib-
ute to our understanding of the function of ORS in sick 
animals, but need to be confirmed in dehydrated and 
acidotic calves. Models of mild acidemia, with or with-
out dehydration, that have been used successfully in 
earlier studies would be suitable to determine whether 
observations of this studies in euhydrated calves can 
be reproduced in states of acidemia and dehydration 
(Iwabuchi et al., 2003; Leal et al., 2012).
CONCLUSIONS
The combination of NaHCO3 with glucose in a hy-
pertonic oral rehydration solution did not enhance the 
alkalinizing effect of NaHCO3 when compared with 
ORS containing NaHCO3 alone. The combination of 
NaHCO3 and glucose did not improve Na, glucose, or 
water absorption in euhydrated neonatal dairy calves, 
bringing into question the relevance of a specific ratio 
between Na and glucose in oral rehydration solutions 
for calves.
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